Makati Medical Center Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2014
NCT04313868
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Makati Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Dermatitis (Phase 1)

Dermatitis, Atopic (Phase 1)

Eczema (Phase 1)

Multiple Sclerosis (Phase 1)

Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 7